Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec 17;1866(3):158870. doi: 10.1016/j.bbalip.2020.158870

Table 3.

AUC (pmol×min/µL), incorporation coefficient (K*) (µL/(mg×min), incorporation rate, Jin ((pmol/(mg×min)), turnover, F (min−1), half life, t1/2 (min) in visceral adipose, liver, and heart in IV and gavage rats.

IV (UE) Gavage (ES)
Plasma d4–13-HODE AUC 16.4 ± 19.3 2.1 ± 1.71

Visceral adipose k* 0.047 ± 0.041 0.88 ± 1.16
Liver k* (×10−4) 3.6 ± 3.8 22.9 ± 12.2ϯ
Heart k* (×10−4) 20.3 ± 21.1 42.4 ± 23.0

Visceral adipose Jin (×10−4) 22.2 ± 17.1 846.2 ± 1250.0
Liver Jin (×10−4) 0.18 ± 0.15 1.9 ± 1.3ϯ
Heart Jin (×10−4) 1.0 ± 1.0 3.2 ± 1.7

Visceral adipose F (×10−4) 1.6 ± 1.5 65.1 ± 72.3ϯ
Liver F (×10−4) 0.15 ± 0.075 1.7 ± 1.1 ϯϯ
Heart F (×10−4) 0.7 ± 0.6 2.2 ± 1.5

Visceral adipose 𝑡1/2 (×104) 0.9 ± 0.9 (6.2 days) 0.05 ± 0.07 (0.34 day)ϯ
Liver 𝑡1/2 (×104) 5.5 ± 2.3 (38.3 days) 0.5 ± 0.3 (3.6 days)ϯϯ
Heart 𝑡1/2 (×104) 2.1 ± 2.3 (14.7 days) 0.4 ± 0.3 (3.1 days)

Data are mean ± SD of n=3 per group.

ϯ

Indicates significant differences in log-transformed values between IV and gavage groups, by unpaired t-test applied to log-transformed values.

1

Esterified d4–13-HODE AUC determined by subtracting free from total d4–13-HODE AUC in each individual rat that received the tracer via gavage.